Unify Peptides
Retatrutide - 20mg vial

Metabolic Compounds

Retatrutide - 20mg

$250.00 CAD

Triple GIP/GLP-1/Glucagon receptor agonist. HPLC-verified ≥99% purity. Lyophilized powder, 20mg per vial.
1

SKU: UP-RETA-20

Availability: In Stock

Category: Metabolic Compounds

Description

Retatrutide (LY-3437943) is a novel triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. This is the larger 20mg research vial for extended studies.

  • Molecular Weight: ~4,813 g/mol
  • Purity: ≥99% (HPLC verified)
  • Form: Lyophilized powder
  • Storage: -20°C, protected from light
  • CAS: 2381089-83-2

Each vial contains 20mg of lyophilized peptide with certificate of analysis included. For research purposes only.